venetoclax plus hmas in idh-mutant aml
Published 3 years ago • 339 plays • Length 5:35Download video MP4
Download video MP3
Similar videos
-
2:25
venetoclax for aml
-
3:08
venetoclax-idh inhibitor combination therapy for aml
-
1:55
first-line venetoclax plus hma vs intensive chemotherapy in older adults with idh-mutated aml
-
1:48
tp53-mutant aml linked to poorer outcomes with decitabine plus venetoclax
-
2:19
cladribine ldac venetoclax alternated with azacitidine venetoclax in older patients with aml
-
3:52
venetoclax & aml
-
1:18
venetoclax combination therapies in aml
-
1:43
cone beam ct imaging with the morita veraview x800
-
4:52
apoptosis and venetoclax
-
6:13
how has acute myeloid leukemia treatment for elderly people changed in 2021?
-
2:31
idh mutations in aml treated with venetoclax
-
2:03
the use of venetoclax in r/r al amyloidosis
-
1:50
the challenge of treating elderly patients with aml with venetoclax plus azacitidine
-
1:40
oral combination of hmas venetoclax in unfit or elderly patients with aml
-
2:16
venetoclax-based salvage therapy in patients with r/r aml previously treated with targeted agents
-
3:25
venetoclax plus idasanutlin for r/r aml: phase i/ii trial
-
3:35
safety and efficacy of venetoclax-based regimens for aml
-
2:05
venetoclax with decitabine for high-risk aml and mds
-
1:43
six-year update from cll14: fixed-duration venetoclax obinutuzumab for previously untreated cll
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
3:11
genetic mutations as poor prognostic indicators of hct in venetoclax-treated aml
-
1:19
new treatments for aml